Advertisement

Topics

French Biotech Raises €19M for a Gene Therapy Trial in Retinitis Pigmentosa

04:48 EST 8 Nov 2017 | Labiotech.eu

Horama has raised a second fundraising round that will support its lead candidate, a gene therapy for retinitis pigmentosa, through clinical trials.  The French company Horama has announced the closing of its Series B round, which has ammassed a total ...

This awesome article French Biotech Raises €19M for a Gene Therapy Trial in Retinitis Pigmentosa appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: French Biotech Raises €19M for a Gene Therapy Trial in Retinitis Pigmentosa

NEXT ARTICLE

More From BioPortfolio on "French Biotech Raises €19M for a Gene Therapy Trial in Retinitis Pigmentosa"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...